journal article·2023-11

Mild Photothermal Therapy Prevents Posterior Capsule Opacification through Cytoskeletal Remodeling

Lei Lin, Liming Xu, Weijie Sun, Lili Liang, Xiaoliang Qi, Yun‐e Zhao

Advanced Healthcare Materials· Volume 12· Issue 29
Publisher page

Abstract

Abstract Cataract is the first leading cause of blindness in the world and posterior capsule opacification (PCO) is the most common long‐term complication after surgery. The primary pathogenic processes contributing to PCO are the proliferation and migration of residual lens epithelial cells (LECs). This study aimed to explore the mild photothermal effect on LECs. Interestingly, this work finds that the mild photothermal effect significantly inhibited the proliferation and migration of LECs. The live cell fluorescence imaging reveals that the remodeling of the actin cytoskeleton and cell morphology attributed to the inhibition effect. Further mechanistic studies at molecular level suggest that the mild photothermal effect can regulate the phosphorylation of ERM, YAP, and Cofilin and thereby affect the proliferation and migration of LECs. In order to explore the potential clinical application of mild photothermal therapy for PCO prevention, PDA/PVA gel rings with photothermal effect is prepared by the repeated freeze‐thaw method and conducted experiments in vivo, which achieved favorable PCO prevention effect. Overall, this study shows that the mild photothermal effect can regulate the proliferation and migration of LECs through cytoskeletal remodeling and the results of experiments in vivo demonstrate that mild photothermal effect is a promising approach for PCO prevention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Intraocular Surgery and Lenses · Connexins and lens biology · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Clinical Research Center for Ocular Diseases Eye Hospital Wenzhou Medical University Wenzhou 325027 China

National Engineering Research Center of Ophthalmology and Optometry Eye Hospital Wenzhou Medical University Wenzhou 325027 China

State Key Laboratory of Ophthalmology Optometry and Vision Science Eye Hospital Wenzhou Medical University Wenzhou 325027 China

Funding

Natural Science Foundation of Zhejiang Province · National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1016/S0140-6736(17)30544-510.1016/S0140-6736(17)30544-5 ↗
2. 10.1076/opep.11.2.67.2815810.1076/opep.11.2.67.28158 ↗
3. 10.1038/sj.eye.670301510.1038/sj.eye.6703015 ↗
4. 10.1097/APO.000000000000008010.1097/APO.0000000000000080 ↗
5. 10.1016/j.jcrs.2016.10.00710.1016/j.jcrs.2016.10.007 ↗
6. Xie Y.‐B. · Int. J. Ophthalmol. · 2018 · 11 · 1403
7. 10.1039/D0TB02530E10.1039/D0TB02530E ↗
8. Karahan E. · Med. Hypothesis Discov. Innov. Ophthalmol. · 2014 · 3 · 45
9. 10.1016/j.jcrs.2017.03.04610.1016/j.jcrs.2017.03.046 ↗
10. 10.1039/D0TB02802A10.1039/D0TB02802A ↗
11. 10.1167/iovs.12-1042510.1167/iovs.12-10425 ↗
12. 10.1016/j.cej.2021.13271610.1016/j.cej.2021.132716 ↗
13. 10.1016/j.jcrs.2019.05.01810.1016/j.jcrs.2019.05.018 ↗
14. 10.1167/iovs.14-1436410.1167/iovs.14-14364 ↗
15. 10.1167/iovs.18-2593010.1167/iovs.18-25930 ↗
16. 10.1021/acsabm.0c0033110.1021/acsabm.0c00331 ↗
17. 10.1021/bm058010l10.1021/bm058010l ↗
18. 10.3928/1081597X-20150623-0510.3928/1081597X-20150623-05 ↗
19. 10.1039/D1RA00201E10.1039/D1RA00201E ↗
20. 10.2147/IJN.S21580210.2147/IJN.S215802 ↗
21. 10.1016/j.actbio.2021.11.01810.1016/j.actbio.2021.11.018 ↗
22. 10.1039/C4NR00708E10.1039/C4NR00708E ↗
23. 10.1021/nn103047r10.1021/nn103047r ↗
24. 10.1021/nl100996u10.1021/nl100996u ↗
25. 10.3390/ma1205077910.3390/ma12050779 ↗
26. 10.1002/adma.20170161710.1002/adma.201701617 ↗
27. 10.1021/acs.nanolett.1c0337710.1021/acs.nanolett.1c03377 ↗
28. Łukaszewska‐Smyk A. · Klin Oczna · 2009 · 111 · 369
29. Zemaitiene R. · Medicina (Kaunas) · 2003 · 39 · 830
30. 10.1038/283139a010.1038/283139a0 ↗
31. 10.1002/9780470376928.ch110.1002/9780470376928.ch1 ↗
32. 10.1038/nrm375810.1038/nrm3758 ↗
33. 10.1042/BCJ2016012810.1042/BCJ20160128 ↗
34. 10.1111/acel.1245010.1111/acel.12450 ↗
35. 10.1039/C9BM00787C10.1039/C9BM00787C ↗
36. 10.3389/fbioe.2018.0010910.3389/fbioe.2018.00109 ↗
37. 10.1021/acsnano.8b0402210.1021/acsnano.8b04022 ↗
38. 10.1016/j.cej.2022.13569110.1016/j.cej.2022.135691 ↗
39. 10.1016/j.ijpharm.2010.03.02410.1016/j.ijpharm.2010.03.024 ↗
40. 10.1016/0032-3861(92)90385-A10.1016/0032-3861(92)90385-A ↗
41. 10.1167/iovs.14-1530210.1167/iovs.14-15302 ↗
42. 10.1158/1535-7163.MCT-04-031010.1158/1535-7163.MCT-04-0310 ↗
43. 10.1002/mabi.20190039410.1002/mabi.201900394 ↗
44. 10.1002/advs.20220335110.1002/advs.202203351 ↗
45. 10.1126/sciadv.aax190910.1126/sciadv.aax1909 ↗
46. 10.1007/s10409-019-00854-110.1007/s10409-019-00854-1 ↗
47. 10.1242/jcs.25923710.1242/jcs.259237 ↗
48. 10.1083/jcb.20180606510.1083/jcb.201806065 ↗
49. 10.1002/adfm.20180173810.1002/adfm.201801738 ↗